Raloxifene-d10
Raloxifene-d10 is the deuterium labeled Raloxifene. Raloxifene (Keoxifene) is a benzothiophene-derived selective estrogen receptor modulator (SERM) . Raloxifene has estrogen-agonistic effects on bone and lipids and estrogen-antagonistic effects on the breast and uterus. Raloxifene is used for breast cancer and osteoporosis research[1].
Product Specifications
UNSPSC
12352005
Target
Estrogen Receptor/ERR; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others; Vitamin D Related/Nuclear Receptor
Field of Research
Cancer
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(C2=CC=C(O)C=C2)SC3=CC(O)=CC=C31)C4=CC=C(OCCN5C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C5([2H])[2H])C=C4
Molecular Formula
C28H17D10NO4S
Molecular Weight
483.64
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Khovidhunkit W, et al. Clinical effects of raloxifene hydrochloride in women. Ann Intern Med. 1999;130 (5) :431-439.|[3]Xu H, et al. Effect of caffeine on ovariectomy-induced osteoporosis in rats. Biomed Pharmacother. 2019;112:108650.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1105639-01 0.02 mg (E-Coli)
Recombinant Mycobacterium sp. Peptide deformylase (def)
Sign In for Pricing
View Details MBS1105639-02 0.1 mg (E-Coli)
Recombinant Mycobacterium sp. Peptide deformylase (def)
Sign In for Pricing
View Details MBS1105639-03 0.02 mg (Yeast)
Recombinant Mycobacterium sp. Peptide deformylase (def)
Sign In for Pricing
View Details MBS1105639-04 0.1 mg (Yeast)
Recombinant Mycobacterium sp. Peptide deformylase (def)
Sign In for Pricing
View Details MBS1105639-05 0.02 mg (Baculovirus)
Recombinant Mycobacterium sp. Peptide deformylase (def)
Sign In for Pricing
View Details